AG
CDLX icon

Algert Global’s Cardlytics CDLX Stock Holding History

Algert Global’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,133
Closed -$48K – 1175
2025
Q4 		$48K Hold
4,133
– – ﹤0.01% 1117
2025
Q3 		$100K Buy
+4,133
New +$68.8K ﹤0.01% 1085
2024
Q2 		– Sell
-1,426
Closed -$207K – 1504
2024
Q1 		$207K Buy
+1,426
New +$120K 0.01% 968
2023
Q1 		– Sell
-1,403
Closed -$81K – 1151
2022
Q4 		$81K Sell
1,403
-8,571
-86% -$529K ﹤0.01% 1085
2022
Q3 		$938K Buy
+9,974
New +$1.42M 0.06% 575
2022
Q1 		– Sell
-500
Closed -$331K – 1190
2021
Q4 		$331K Buy
500
+103
+26% +$78.7K 0.04% 696
2021
Q3 		$333K Buy
+397
New +$403K 0.04% 720
2020
Q1 		– Sell
-844
Closed -$531K – 421
2019
Q4 		$531K Buy
+844
New +$413K 0.16% 199

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Algert Global's CDLX Position: Q1 2026 in Review

Algert Global sold out of Cardlytics (CDLX) in Q1 2026, closing a stake of 4,133 shares — an estimated $48K sold.

Algert Global first reported a position in CDLX in Q4 2019 and held it in 8 quarters. The position peaked at $938K in Q3 2022. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • Algert Global reported no remaining Cardlytics position as of Q1 2026 after selling out during the quarter.
  • Algert Global sold 4,133 Cardlytics shares in Q1 2026, an estimated $48K.
  • Algert Global first reported a position in Cardlytics in Q4 2019 and held it in 8 quarters.
  • Algert Global's Cardlytics position peaked at $938K in Q3 2022.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.